In a world-first clinical trial, lab-grown red blood cells have been transfused into humans. If successful, its continuation will bolster supplies for those with rare blood types and improve treatment for people who require regular transfusions.
You’ve heard of lab-grown meat, but what about lab-grown human blood?
For the very first time, a couple of spoonfuls (5-10ml) of lab-grown blood have been injected into volunteers participating in the RESTORE randomised controlled clinical trial in the UK.
These trials, if successful, would help to meet blood supplies for people with unique blood types. Professors at the University of Bristol said certain blood groups are so rare that they can only find matches in 10 people across the UK.
Looking to the future, lab-manufactured blood cells could revolutionise treatment for patients with rare blood types and conditions such as sickle cell and thalassemia.
Those living with these diseases rely on donated blood for regular transfusions, which can become more complex to accomplish over time.
Scientists started manufacturing lab-grown red blood cells using stem cells from human blood donors.
They have anticipated that cells grown in the lab will outperform standard donated blood, as the lab-grown cells are far fresher. If correct, this would mean that patients regularly receiving blood transfusions won’t need to get them as often.
Better performing lab-grown cells would also mean fewer transfusions needed per patient. This would lower the risk of patients experiencing iron overload, a complication sometimes seen in people receiving regular blood transfusions.
Dr Farrukh Shah, Medical Director of Transfusion for NHS Blood and Transplant, said:
‘Patients who need regular or intermittent blood transfusions may develop antibodies against minor blood groups. [This] makes it harder to find donor blood which can be transfused without the risk of a potentially life-threatening reaction.’
Monitoring the results
The NIHR Cambridge Clinical Research Facility is overseeing the clinical trial, having recruited two healthy volunteers.
So far, the two volunteers are healthy and well, showing no side effects. In the coming months, a minimum of ten more volunteers are expected to receive two mini-transfusions – both lab-grown and traditional – at least four months apart.
The goal of this dual trial is to compare the lifespan of the two types of blood donations in the body, to see whether lab-grown blood is longer-lasting in its positive effects.
Hopefully, the success of the trial will advance the mission to make lab-grown red blood cells more widely available for people who need it.
Professor Lucy Chappell, Chief Executive of the NIHR said:
‘These NIHR-supported researchers have made it possible to grow blood in the lab, turning what sounds like science fiction into a ground-breaking reality… This is really exciting progress that is another example of the world-leading life sciences opportunities that the UK has to offer.’
Fingers crossed the trial goes well, as over 2.5 million units of blood are transfused into UK patients by the NHS every year!
Deputy Editor & Content Partnership ManagerLondon, UK
I’m Jessica (She/Her). I’m the Deputy Editor & Content Partnership Manager at Thred. Originally from the island of Bermuda, I specialise in writing about ocean health and marine conservation, but you can also find me delving into pop culture, health and wellness, plus sustainability in the beauty and fashion industries. Follow me on Twitter, LinkedIn and drop me some ideas/feedback via email.
The Israeli government has announced plans to establish 22 illegal settlements in the occupied West Bank, in what officials say is deliberate attempt to thwart the establishment of a Palestinian state.
Despite looming sanctions from its international allies, the Israeli government has announced plans to build 22 new settlements in the occupied West Bank.
Israeli defence minister Yisrael Katz led the motion, announcing that the new settlements intended to ‘prevent...
When London’s green sanctuaries become private playgrounds, who truly holds the key to public space?
Last month, Brockwell Park underwent its annual transformation from local haven to festival fortress. Surrounded by temporary fencing and housing a swathe of stages and food vans, tens of thousands prepared to descend on the park over a series of weekends.
The beloved patch of greenery has been home to a run of music events for...
A new report backed by the Mayor of London calls for some cannabis possession to be decriminalised in the capital.
Sadiq Khan is supporting calls for the partial decriminalisation of cannabis in the UK capital, following a study by the independent London Drugs Commission (LDC).
According to reports by the LDC, the global policing of drug usage – particularly cannabis, which remains the most contentious substance when it comes to international...
In a pivotal moment for global health cooperation, the US has chosen not to sign the world’s first international pandemic agreement, distancing itself from the future of pandemic preparedness.
The COVID-19 pandemic tested the world in circumstances that were never before seen. From governments, to the public, the crisis exposed vulnerabilities and resilience across health, economic, and social systems on a global scale.
Nations with robust social safety nets and responsive...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
0 Comments
